Roche Holding AG (RHHBY)


Other OTC - Other OTC Delayed Price. Currency in USD
31.27-0.27 (-0.86%)
As of 12:36 PM EDT. Market open.
People also watch:
NVSSNYNSRGYAZNBAYRY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open31.36
Prev Close31.54
Bid0.00 x
Ask0.00 x
Day's Range31.25 - 31.41
52wk Range29.89 - 35.13
1y Target EstN/A
Market Cap213.18B
P/E Ratio (ttm)23.24
Beta0.66
Volume193,244
Avg Vol (3m)929,984
Dividend & Yield1.02 (3.23%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Investor's Business Daily14 minutes ago

    Unexpected Twist: Pfizer Scraps Breakup Following Dead Allergen Merger

    Pfizer ended years of speculation that it would split into separate businesses, one focused on new drugs and the other on off-patent drugs.

  • PR Newswire1 hour ago

    Roche receives 510(k) clearance from FDA for Treponema pallidum assay to aid clinicians in the diagnosis of syphilis infection

    OTCQX: RHHBY) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a fully automated assay for the detection of antibodies to Treponema pallidium for use on all Roche immunoassay systems for low-, mid- and high-volume testing environments, including the cobas e 411, cobas e 601, cobas e 602 and MODULAR ANALYTICS E170 analyzers. The Treponema pallidum assay is intended as an aid in the diagnosis of syphilis infection. The Roche Syphilis treponemal antibody test offers several advantages, including a specific screening test that provides an objective result, high throughput on an automated analyzer, and high specificity.

  • PR Newswire4 hours ago

    Roche launches low-cost PT/INR home monitoring app

    INDIANAPOLIS, Sept. 26, 2016 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the CoaguChek XS mPOC app for use with the CoaguChek XS meter.   The new app makes the Bluetooth-enabled ...